Hooman Hajian

Hooman Hajian, MD, MPH, is an accomplished medical professional with extensive experience in clinical development and medical strategy. Currently serving as the Group Medical Director for Clinical Development at AbbVie, Hooman has previously held key positions such as Senior Medical Director at Alexion Pharmaceuticals, Senior Medical Director at Gilead Sciences, and Medical Director at IQVIA. Hooman is also a Physician Member of the Institutional Review Board at Quorum Review IRB (now Advarra). Education includes a fellowship in Nephrology and Hypertension from the University of Washington and a Master of Public Health from Harvard T.H. Chan School of Public Health.